• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草酸钙结石形成抑制作用的研究:一种筛选硫化氢及其代谢产物的体外方法

Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites.

作者信息

Vaitheeswari S, Sriram R, Brindha P, Kurian Gino A

机构信息

School of Chemical and Biotechnology, SASTRA University, Thanjavur, T. N, India.

Vascular Biology Lab, SASTRA University, Thanjavur, T. N, India.

出版信息

Int Braz J Urol. 2015 May-Jun;41(3):503-10. doi: 10.1590/S1677-5538.IBJU.2014.0193.

DOI:10.1590/S1677-5538.IBJU.2014.0193
PMID:26200543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4752143/
Abstract

PURPOSE

Calcium oxalate urolithiasis is one of the most common urinary tract diseases and is of high prevalence. The present study proposes to evaluate the antilithiatic property of hydrogen sulfide and its metabolites like thiosulfate & sulfate in an in vitro model.

MATERIALS AND METHODS

The antilithiatic activity of sodium hydrogen sulfide (NaSH), sodium thiosulfate (Na(2)S(2)O(3)) and sodium sulfate (Na(2)SO(4)) on the kinetics of calcium oxalate crystal formation was investigated both in physiological buffer and in urine from normal and recurrent stone forming volunteers. The stones were characterized by optical and spectroscopic techniques.

RESULTS

The stones were characterized to be monoclinic, prismatic and bipyramidal habit which is of calcium monohydrate and dihydrate nature. The FTIR displayed fingerprint corresponding to calcium oxalate in the control while in NaSH treated, S=O vibrations were visible in the spectrum. The order of percentage inhibition was NaSH>Na(2)S(2)O(3)>Na(2)SO(4).

CONCLUSION

Our study indicates that sodium hydrogen sulfide and its metabolite thiosulfate are inhibitors of calcium oxalate stone agglomeration which makes them unstable both in physiological buffer and in urine. This effect is attributed to pH changes and complexing of calcium by S(2)O(3)(2)-and SO(4)(2)- moiety produced by the test compounds.

摘要

目的

草酸钙尿路结石是最常见的泌尿系统疾病之一,发病率很高。本研究旨在评估硫化氢及其代谢产物如硫代硫酸盐和硫酸盐在体外模型中的抗结石特性。

材料与方法

研究了硫化钠(NaSH)、硫代硫酸钠(Na₂S₂O₃)和硫酸钠(Na₂SO₄)对正常及复发性结石形成志愿者的生理缓冲液和尿液中草酸钙晶体形成动力学的抗结石活性。通过光学和光谱技术对结石进行表征。

结果

结石的特征为单斜、棱柱和双锥体习性,具有一水合钙和二水合钙的性质。傅里叶变换红外光谱(FTIR)显示对照组中对应草酸钙的指纹图谱,而在NaSH处理组中,光谱中可见S=O振动。抑制百分比的顺序为NaSH>Na₂S₂O₃>Na₂SO₄。

结论

我们的研究表明,硫化氢钠及其代谢产物硫代硫酸盐是草酸钙结石聚集的抑制剂,这使得它们在生理缓冲液和尿液中都不稳定。这种作用归因于测试化合物产生的pH变化以及S₂O₃²⁻和SO₄²⁻部分对钙的络合作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/324f423d0f7b/1677-5538-ibju-41-3-0503-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/efe6290e224f/1677-5538-ibju-41-3-0503-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/da1efed0ce14/1677-5538-ibju-41-3-0503-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/f409279a8839/1677-5538-ibju-41-3-0503-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/0caa16340003/1677-5538-ibju-41-3-0503-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/324f423d0f7b/1677-5538-ibju-41-3-0503-gf05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/efe6290e224f/1677-5538-ibju-41-3-0503-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/da1efed0ce14/1677-5538-ibju-41-3-0503-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/f409279a8839/1677-5538-ibju-41-3-0503-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/0caa16340003/1677-5538-ibju-41-3-0503-gf04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f998/4752143/324f423d0f7b/1677-5538-ibju-41-3-0503-gf05.jpg

相似文献

1
Studying inhibition of calcium oxalate stone formation: an in vitro approach for screening hydrogen sulfide and its metabolites.草酸钙结石形成抑制作用的研究:一种筛选硫化氢及其代谢产物的体外方法
Int Braz J Urol. 2015 May-Jun;41(3):503-10. doi: 10.1590/S1677-5538.IBJU.2014.0193.
2
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.白蛋白介导的草酸钙晶体成核作用:对预防结石形成的影响。
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
3
Endothelium corneum gigeriae galli extract inhibits calcium oxalate formation and exerts anti-urolithic effects.鸡内金提取物抑制草酸钙形成并发挥抗结石作用。
J Ethnopharmacol. 2019 Mar 1;231:80-89. doi: 10.1016/j.jep.2018.09.003. Epub 2018 Sep 5.
4
Antilithiatic Activity of phlorotannin rich extract of Sarghassum Wightii on Calcium Oxalate Urolithiais - InVitro and In Vivo Evaluation.半叶马尾藻富含间苯三酚鞣质提取物对草酸钙尿路结石的抗结石活性——体内外评价
Int Braz J Urol. 2015 May-Jun;41(3):511-20. doi: 10.1590/S1677-5538.IBJU.2014.0357.
5
Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.晶内蛋白质与尿石症:一水草酸钙和二水草酸钙晶体蛋白质含量及超微结构的比较
BJU Int. 2005 Sep;96(4):654-63. doi: 10.1111/j.1464-410X.2005.05701.x.
6
Clinical manifestations of calcium oxalate monohydrate and dihydrate urolithiasis.一水草酸钙和二水草酸钙尿路结石的临床表现。
J Urol. 1982 Jun;127(6):1067-9. doi: 10.1016/s0022-5347(17)54229-9.
7
Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.从人肾结石基质中分离出的一种蛋白质抑制剂在尿路结石形成中的作用
Indian J Biochem Biophys. 2005 Apr;42(2):113-7.
8
Production of heparan sulfate in the process of calcium oxalate microlith formation.在草酸钙微石形成过程中肝素硫酸的产生。
Int J Urol. 1996 Jan;3(1 Suppl):S69-71. doi: 10.1111/j.1442-2042.1996.tb00092.x.
9
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.遗传性高钙尿结石形成大鼠的草酸钙结石形成
Kidney Int. 2002 Mar;61(3):975-87. doi: 10.1046/j.1523-1755.2002.00190.x.
10
Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis.乙二醇诱导马尔皮基氏小管内草酸钙晶体沉积:肾结石/尿结石的果蝇模型。
Kidney Int. 2011 Aug;80(4):369-77. doi: 10.1038/ki.2011.80. Epub 2011 Mar 30.

引用本文的文献

1
Hydrogen Sulfide Deficiency Contributes to Tubular Damage and Calcium Oxalate Crystal Formation in Hyperoxaluria Nephropathy: Role of Osteopontin and Tamm-Horsfall Protein.硫化氢缺乏促进高草酸尿肾病中的肾小管损伤和草酸钙晶体形成:骨桥蛋白和Tamm-Horsfall蛋白的作用
Antioxidants (Basel). 2025 Sep 5;14(9):1088. doi: 10.3390/antiox14091088.
2
Linking basic principles of solution chemistry to kidney stone formation timelines.将溶液化学的基本原理与肾结石形成时间线联系起来。
Sci Rep. 2025 Jul 1;15(1):20625. doi: 10.1038/s41598-025-07193-1.
3
Sulfur-Containing Amino Acids, Hydrogen Sulfide, and Sulfur Compounds on Kidney Health and Disease.

本文引用的文献

1
Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.肾结石:肾结石形成的分子机制和调节剂的关键作用。
Biomed Res Int. 2013;2013:292953. doi: 10.1155/2013/292953. Epub 2013 Sep 14.
2
A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.硫代硫酸钠对非结石形成者和高钙尿结石形成者尿结石形成性和相关代谢性酸负荷的影响的初步研究。
PLoS One. 2013 Apr 8;8(4):e60380. doi: 10.1371/journal.pone.0060380. Print 2013.
3
Recent finding and new technologies in nephrolitiasis: a review of the recent literature.
含硫氨基酸、硫化氢及硫化合物对肾脏健康与疾病的影响
Metabolites. 2023 May 25;13(6):688. doi: 10.3390/metabo13060688.
4
Roles of Hydrogen Sulfide Donors in Common Kidney Diseases.硫化氢供体在常见肾脏疾病中的作用
Front Pharmacol. 2020 Nov 19;11:564281. doi: 10.3389/fphar.2020.564281. eCollection 2020.
5
The role of the gasotransmitter hydrogen sulfide in pathological calcification.气体信号分子硫化氢在病理性钙化中的作用。
Br J Pharmacol. 2020 Feb;177(4):778-792. doi: 10.1111/bph.14772. Epub 2019 Jul 24.
6
The renal mitochondrial dysfunction in patients with vascular calcification is prevented by sodium thiosulfate.硫代硫酸钠可预防血管钙化患者的肾线粒体功能障碍。
Int Urol Nephrol. 2016 Nov;48(11):1927-1935. doi: 10.1007/s11255-016-1375-z. Epub 2016 Jul 27.
肾结石研究的新发现和新技术:对近期文献的综述。
BMC Urol. 2013 Feb 16;13:10. doi: 10.1186/1471-2490-13-10.
4
Hydrogen sulfide in biochemistry and medicine.硫化氢在生物化学和医学中的作用
Antioxid Redox Signal. 2012 Jul 1;17(1):119-40. doi: 10.1089/ars.2012.4612. Epub 2012 Apr 20.
5
History, epidemiology and regional diversities of urolithiasis.尿石症的历史、流行病学和地域差异。
Pediatr Nephrol. 2010 Jan;25(1):49-59. doi: 10.1007/s00467-008-0960-5.
6
Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris.水提三芪对草酸诱导的肾小管上皮细胞损伤的抑制作用及对草酸钙结晶的抑制作用。
Int Braz J Urol. 2010 Jul-Aug;36(4):480-8; discussion 488, 489. doi: 10.1590/s1677-55382010000400011.
7
Hydrogen sulfide: its production, release and functions.硫化氢:其生成、释放与功能。
Amino Acids. 2011 Jun;41(1):113-21. doi: 10.1007/s00726-010-0510-x. Epub 2010 Feb 27.
8
Strain-related differences in urine composition of male rats of potential relevance to urolithiasis.与结石形成潜在相关的雄性大鼠尿液成分的品系差异。
Toxicol Pathol. 2009 Apr;37(3):293-305. doi: 10.1177/0192623309332990.
9
Thiosulfate reduces calcium phosphate nephrolithiasis.硫代硫酸盐可减轻磷酸钙肾结石。
J Am Soc Nephrol. 2009 Jun;20(6):1246-53. doi: 10.1681/ASN.2008070754. Epub 2009 Apr 15.
10
Physiopathology and etiology of stone formation in the kidney and the urinary tract.肾脏和泌尿道结石形成的病理生理学和病因学。
Pediatr Nephrol. 2010 May;25(5):831-41. doi: 10.1007/s00467-009-1116-y. Epub 2009 Feb 7.